Hypertensive Treatment and the Metabolic Syndrome
Journal:
Current Hypertension Reviews
Volume:
7
Page:
172-183
Author(s):
David Siegel and Arthur L.M. Swislocki
Treatments for Obesity-Related Hypertension
Journal:
Current Hypertension Reviews
Volume:
7
Page:
184-199
Author(s):
Kazuko Masuo
Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
Journal:
Current Vascular Pharmacology
Volume:
9
Page:
698-705
Author(s):
Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis and Dimitri P. Mikhailidis
Treatment of Cardiovascular Calcification in Uremia
Journal:
Current Vascular Pharmacology
Volume:
9
Page:
741-749
Author(s):
Sandro Mazzaferro, Marzia Pasquali and Mario Cozzolino
Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Journal:
Current Drug Targets
Volume:
12
Page:
1595-1653
Author(s):
Bharat B. Aggarwal, Sahdeo Prasad, Simone Reuter, Ramaswamy Kannappan, Vivek R. Yadav, Byoungduck Park, Ji Hye Kim, Subash C. Gupta, Kanokkarn Phromnoi, Chitra Sundaram, Seema Prasad, Madan M. Chaturvedi and Bokyung Sung
Stem Cell-Based Immunomodulation in Type 1 Diabetes: Beyond the Regenerative Approach
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3229-3242
Author(s):
Biancamaria Longoni and Franco Mosca
The Blockade of Renin-Angiotensin-Aldosterone System in Hemodialysis Patients to Control Hypertension and Prevent Cardiovascular Disease: Optimal Pharmacotherapy
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
9
Page:
241-246
Author(s):
Yoshiyuki Morishita and Eiji Kusano
A Review of Oxidative Stress Related Genes and New Antioxidant Therapy in Diabetic Nephropathy
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
9
Page:
253-261
Author(s):
Jana Makuc and Danijel Petrovic
ROS Acts as a Double-Edged Sword in the Pathogenesis of Type 2 Diabetes Mellitus: Is Nrf2 a Potential Target for the Treatment?
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
11
Page:
1082-1092
Author(s):
X. Wang and C. X. Hai
Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Journal:
Current Drug Targets
Volume:
12
Page:
1498-1512
Author(s):
Georgios S. Papaetis, Dora Orphanidou and Themistoklis N. Panagiotou